Chemistry:3-Me-PCE
From HandWiki
3-Me-PCE is the 3-methyl derivative of the internationally controlled substance Eticyclidine (PCE). It shares structural similarities with 3-MeO-PCE and 3-HO-PCE. 3-Me-PCE first appeared in the scientific literature in 2015 in the context of synthesis and analytical caracterization of a series of arylcyclohexylamines by Wallach et al. It is believed to produce ketamine-like dissociative effects predominantly via antagonism of NMDA receptors.[1] Anecdotal evidence of its efficacy dates back to 2022 and assigns it a potency similar to other PCE analogs.[2] The EUDA issued a notification of its first analytical identification in March 2024.[3]
See also
References
- ↑ "Syntheses and analytical characterizations of N-alkyl-arylcyclohexylamines" (in en). Drug Testing and Analysis 8 (8): 801–815. 2016. doi:10.1002/dta.1861. ISSN 1942-7611. PMID 26360516. https://onlinelibrary.wiley.com/doi/abs/10.1002/dta.1861.
- ↑ "3-Me-PCE - Erowid Exp - 'The Electric Fog'". https://erowid.org/experiences/exp.php?ID=116001.
- ↑ "EU Early Warning System Formal Notification: N‑ethyl‑1‑(3‑methylphenyl)cyclohexan‑1‑amine (3‑Me‑PCE)". European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). 11 March 2024. https://workpage.ews-nfp.bg/wp-content/uploads/2024/03/EU-EWS-RCS-FN-2024-0004_3-Me-PCE.pdf.
 |  |
